A KEIGHLEY deli owner is taking part in clinical trials of a new drug which could transform bladder cancer treatment.

Researchers from Iwate Medical University and Tohoku University have revealed that it is possible to predict cancer relapse and treatment response by measuring circulating tumor DNA (ctDNA), in tandem ...